Long-term urinary continence and influencing factors after salvage radiotherapy: results of the SAKK 09/10 dose escalation trial.
Christina Schröder, Daniel R Zwahlen, Sämi Schär, Tobias Hölscher, Winfried Arnold, Bülent Polat, Guido Hildebrandt, Arndt-Christian Müller, Paul Martin Putora, Alexandros Papachristofilou, Corinne Schär, Stefanie Hayoz, Marcin Sumila, Kathrin Zaugg, Matthias Guckenberger, Piet Ost, Davide Giovanni Bosetti, Christiane Reuter, Silvia Gomez, Kaouthar Khanfir, Marcus Beck, Oliver Riesterer, George N Thalmann, Daniel M Aebersold, Pirus Ghadjar, Swiss Group for Clinical Cancer Research SAKK
Radiother Oncol 211 111040
摘要
摘要
PURPOSE: This study aimed to investigate late urinary incontinence (UI) after salvage radiotherapy (sRT) and the effect of dose escalation on late UI, incontinence recovery, and quality of life (QoL) as part of the SAKK 09/10 phase III trial. METHODS: The SAKK 09/10 trial was a multicenter, randomized, controlled trial for prostate cancer patients receiving sRT. Eligible patients were randomized to receive either conventional (64 Gy) or dose-escalated (70 Gy) sRT. Baseline and follow-up data were collected on urinary incontinence related QoL, and treatment toxicity. RESULTS: 344 evaluable patients were analyzed. Baseline incontinence (≥Grade (G)1) was reported in 32.2 % of patients, with 8.7 % having ≥ G2. During follow-up (median 6.2 years), 47.2 % of the initially continent (<G1) patients showed a statistically significant (p < 0.001) decline in continence with no significant difference between the treatment groups (p = 0.17). Of the initially incontinent patients, 54.1 % showed an improvement whilst 16.2 % showed further decline. 29.7 % had stable UI. There was no significant difference between the treatment arms (p = 0.36). In multivariable logistic regression, nerve sparing technique was associated with less UI at 24 months (p = 0.029) and at 60 months age (p = 0.031) and resection status (p = 0.046) were significant. There was a steady worsening of urinary symptoms reported over 60 months post RT, with an increase in the symptom scales from a mean of 15.9 at baseline to 22.9 at 60 months. CONCLUSION: More than half of the patients that were continent at baseline remained continent during follow up while incontinent patients showed a variable course. UI was not different between the RT treatment arms.
KM 提取结果
0 个 Figure · 0 个 KM 面板